While cannabidiol (CBD) continues to enjoy its time in the spotlight as an effective treatment for many illnesses, there are other cannabinoids people know very little about. One such cannabinoid that has not received its due recognition is cannabigerol CBG. This variety is often referred to as “the first cannabinoid” because it is the first cannabinoid that develops in cannabis sativa plants and is responsible for the production of CBD.
So that you have all the facts on both these cannabinoids and their uses, we’re going to lay out the differences between these two chemicals.
What is CBD?
CBD is a hemp-derived oil with high concentrations of CBD, low concentrations of THC and is non-psychoactive. Although cannabidiol is one of many cannabinoids found in the Cannabis Sativa plant, including CBG, cannabidiol is distinct from CBG in terms of chemical structure and concentration within the plant.
Research indicates CBD oil benefits include its use as a neuroprotectant and potentially effective therapy for pain and numerous illnesses, including epilepsy, anxiety, arthritis, chronic pain, and cancer. With CBD showing such promise in treating these conditions, it is understandable that the wellness industry is abuzz with the addition of other cannabinoids. Moreover, as researchers continue to study CBD, the lesser known cannabinoid, CBG) is making its way to the forefront of the health industry.
What is CBG?
While CBD is well-known around the globe as a popular supplement, CBG is relatively unheard of. This “first” or “stem cell” cannabinoid compound has the highest concentrations in flowering cannabis plants. Before cannabinoids are converted to THC or CBD, they are first CBG. It is after harvesting, drying and processing that the CBG is found in trace amounts, which has many experts deeming it a minor cannabinoid. Like its fellow cannabinoid, CBD, CBG does not have hallucinogenic properties.
Many findings show that CBG has significant healing properties and could be beneficial as an anti-inflammatory, antibacterial, antifungal, antioxidant, appetite stimulant, and neuroprotectant. Early studies suggest Cannabigerol may effectively treat many conditions, including the following:
- Colon Cancer
- Overactive Bladder
- Psoriasis and Eczema
- Inflammatory bowel disease
- Chronic pain
- Huntington’s disease
- Methicillin-resistant Staphylococcus Aureus (MRSA)
It is noted that a combination of CBG with other cannabinoids may prove to be a superior treatment. This blend is referred to as the “entourage effect” and involves the compounds working synergistically, boosting therapeutic benefits.
Although results are exciting and promising in using CBG in the treatment of many ailments, it is evident there is much more to be learned. Research has only begun to scratch the surface on the benefits of the hemp plant and its cannabinoids. With the growing popularity and the high demand for CBD products in today’s wellness industry, it is only a matter of time before we recognize CBG as CBD’s equal.
As a B2B manufacturer and seller of CBD oil products, Hemp Labs of America can help your business grow. If you would like more information on how our company can assist you with our CBD manufacturing, R&D and CBD Turnkey Operations, contact us today.